Median Technologies SA

01/14/2022 | Press release | Distributed by Public on 01/14/2022 10:51

Median Technologies: Half Year Liquidity Contract Statement

Median Technologies: Half Year Liquidity Contract Statement

Subscribe

14 Jan 2022 17:45 CET

Company Name

MEDIAN TECHNOLOGIES

ISN

FR0011049824

Market

Euronext Growth

Symbol

ALMDT

Regulatory News:

Under the liquidity contract entrusted by Median Technologies (Paris:ALMDT) (FR0011049824 - ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account as of 12/31/2021:

  • 20,093 shares
  • € 231,217.23 in cash

During the second half of 2021, it has been traded a total of:

BUY

111,445 Shares

EUR 1,630,039.38

494 transactions

SELL

108,704 Shares

EUR 1,619,230.25

397 transactions

It is recalled that at the time of the half-yearly statement of 06/30/2021, the following resources were included in the liquidity account:

  • 17,352 shares
  • € 245,154.23 in cash

It is recalled that when the new liquidity contract was put in place on 05/04/2020, the following resources were made available:

  • 4,404 shares
  • € 173,829.64 in cash

The daily transaction table is provided in the appendix to this press release.

TP ICAP (Europe) is authorized and regulated by the Autorité de Contrôle Prudentiel et de Résolution (ACPR) and the Autorité des Marchés Financiers (AMF).

About Median Technologies:Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label "Innovative company" by the BPI and is listed on Euronext Growth market (Paris). FR0011049824- ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005290/en/

Median Technologies
Emmanuelle Leygues
Head of Corporate & Marketing Communications
+33 6 10 93 58 88
[email protected]

Press - ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
[email protected]

Investors - ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
[email protected]

Source

MEDIAN TECHNOLOGIES

Provider

BusinessWire